Premium Information is available for this item - Upgrade for $1 a day
6505-01-239-4660
Dobutamine Hydrochloride Injection
6505012394660 012394660 DOBUTREX 7175 NDC00002-7175-01
INC: 37815 Dobutamine Hydrochloride Injection
January 2023
9
Marketplace 6505-01-239-4660
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-239-4660 5+ Documents (More...)
Dobutamine Hydrochloride Injection 012394660 DOBUTREX7175NDC00002-7175-01 Managed by United States NSN
Dobutamine Hydrochloride Injection 012394660 6505/us 6505-01-239-4660 Dobutamine Hydrochloride
Dobutamine Hydrochloride Injection 012394660 Hydrochloride Injection 145741754 Hydrochloride Injection
145741754 6505- 01-239-4660 1754 Injection 144683197 6505/us 6505-01-239-4660 Dobutamine Hydrochloride
Dobutamine Hydrochloride Injection 012394660 Dobutamine Hydrochloride Injection 145741754 Hydrochloride
Injection 145741754 6505- 01-239-4660 Dobutamine Hydrochloride Injection 1457417546505-14-574-1754 RQST
fsc-6505/pl 6505-43-001-0907 Dobutamine Hydrochloride Injection 430010907 Injection 145741754 6505- 01-239-4660
430010034 https -65/fsc-6505/pl 6505-43-001-0907 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-239-4660
0602 Dobutamine Hydrochloride Injection 190010602 0602 Dobutamine Hydrochloride Injection 190010602 012394660
Dobutamine 001-0034 6505-19-000-9782 6505-01-239-4660 6505-43-001-0907 6505-14-574-1754 6505-19-001-
Restrictions 6505-01-239-4660
6505-01-239-4660 is a Dobutamine Hydrochloride Injection that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. This item does not contain a precious metal.
Import and Export 6505-01-239-4660
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-01-239-4660
- Singapore (YJ01)
- Effective Date:
- 1 Jul 1994
- Canada (ZC01)
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-01-239-4660
- Part Number
- Manufacturer
- Status
- 7175
- Manufacturer
- 75602 - Eli Lilly And Company (Active)
- Primary Buy
- Primary Buy
- NDC00002-7175-01
- 75602 - Eli Lilly And Company (Active)
- Primary Buy
- Primary Buy
- DOBUTREX
- 75602 - Eli Lilly And Company (Active)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
Datasheet 6505-01-239-4660
- Characteristic
- Specifications
- FIIG
- Specifications
- A45100
- Active Medicament Medicinal Strength [AKJA]
- 250.000 Milligrams Dobutamine Equivalent
- Administration [CSGS]
- Intravenous
- Primary Container Type [CQCT]
- Vial, Single Dose
- Primary Container Content Quantity [CRLK]
- 20.000 Milliliters
- Part Name Assigned By Controlling Agency [CXCY]
- Dobutamine Hydrochloride Injection 250Mg 20Ml Single Dose Vial
Similar Supply Items to 6505-01-239-4660
Freight Information 6505-01-239-4660
6505-01-239-4660 has freight characteristics.. 6505-01-239-4660 has a variance between NMFC and UFC when transported by rail and the description should be consulted.